Loading interface...

Pexopram 0.25 Tablet

Manufactured byLa Renon Healthcare
ContainsPramipexole
Description

Pexopram 0.25 Tablet is used to treat restless legs syndrome and to control the symptoms of Parkinson's disease. This medicine is not recommended for use in patients less than 18 years of age.

How will this medicine affect me?

Consult top doctors online and get an answer now
Chat now
Chat now

Looking for a doctor?

Book an appointment with the top doctors near you
Book now
Book now

Substitutes

List of substitutes for Pexopram 0.25 Tablet

MOVEXOL 0.25 mg TABLET
Lupin Ltd.
Pramirol-0.25 Tablet
Intas Pharmaceuticals Ltd.

Side effects

Major & minor side effects for Pexopram 0.25 Tablet

  • Dizziness
  • Drowsiness
  • Nausea
  • Trouble sleeping
  • Unusual tiredness or weakness
  • Cough
  • Muscle weakness
  • Difficulty with swallowing
  • Chest tightness

Uses of Pexopram 0.25 Tablet

What is it prescribed for?

  • Parkinson's Disease
  • Restless Legs Syndrome
Read More
Concerns

Commonly asked questions

  • How long does it take for this medicine to take effect?
    Immediate-release formulations: The peak effect of this medicine can be observed within 2 hours of administration of the dose. Extended/Sustained-release formulations: The peak effect of this medicine can be observed within 6 hours of administration of the dose.
  • How long do the effects of this medicine last?
    Immediate-release formulations: The effect of this medicine lasts for an average duration of 8 to 12 hours. Extended/Sustained-release formulations: The effect of this medicine lasts for an average duration of 24 hours.
  • Is it safe to consume alcohol while taking this medicine?
    Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects such as drowsiness, dizziness, difficulty concentrating, etc.
  • Is this a habit forming medicine?
    No habit-forming tendencies were reported.
  • Can this medicine be taken during pregnancy?
    This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.
  • Can this medicine be taken while breast-feeding?
    This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.

Allergy

This medicine is not recommended for use in patients with a known allergy to pramipexole or any other inactive ingredients present along with this medicine.
Warnings for special population

Pregnancy

This medicine is not recommended for use in pregnant women unless necessary. All the risks and benefits should be discussed with the doctor before taking this medicine.

Breast-feeding

This medicine is not recommended for use in breastfeeding women unless absolutely necessary. All the risks and benefits should be discussed with the doctor before taking this medicine. Your doctor may prescribe a safer alternative based on your clinical condition.
General warnings

Renal impairment

This medicine should be used with caution in patients with kidney function impairment due to the increased risk of severe adverse effects. Report any unusual symptoms to the doctor immediately. Close monitoring of kidney function tests, appropriate dose adjustments, or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Dyskinesia

This medicine should be used with caution in patients suffering from dyskinesia (abnormal, uncontrolled movements) due to the increased risk of worsening of the patient's condition. Close monitoring of clinical condition, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Orthostatic Hypotension

This medicine should be used with extreme caution in patients suffering from hypotension (low blood pressure) or patients receiving high blood pressure medicines due to the increased risk of a very low blood pressure. Regular monitoring of blood pressure levels is required for these patients to safely use this medicine. Appropriate dose adjustments or replacement with a suitable alternative may be necessary based on the clinical condition of the patient.

Use in pediatrics

This medicine is not recommended for use in patients less than 18 years of age since the safety and efficacy of use are not clinically established.

Driving or Operating machinery

Use of this medicine may cause symptoms such as dizziness, drowsiness, etc. in some patients. It is advised that you do not perform any activities such as driving a vehicle or operating machinery if you experience any of these symptoms during treatment with this medicine.

Missed Dose

Take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose. Do not double your dose to make up for the missed one.

Overdose

Seek emergency medical treatment or contact the doctor in case of an overdose.
All drugs interact differently for person to person. You should check all the possible interactions with your doctor before starting any medicine.
Interaction with Alcohol

Description

N/A

Instructions

Consumption of alcohol is not recommended during treatment with this medicine due to the increased risk of severe adverse effects such as drowsiness, dizziness, difficulty concentrating, etc.
Interaction with Medicine

Amitriptyline

Propoxyphene

Sodium oxybate

Amoxapine

Carbamazepine

Baclofen

Dextromethorphan

Disease interactions

Renal Dysfunction

This medicine should be used with extreme caution in patients with a history of kidney diseases due to the increased risk of severe adverse effects. Close monitoring of kidney function tests, appropriate dose adjustments, or replacement with a suitable alternative may be required based on the clinical condition of the patient.

Psychiatric disorders

This medicine should be used with extreme caution in patients with a history of psychiatric disorders due to the increased risk of worsening of the patient's condition. Close monitoring of these patients for any change in mood or behavior is recommended. Appropriate dose adjustments or replacement with a suitable alternative may be required based on the clinical condition.

Neuroleptic Malignant Syndrome

This medicine is not recommended for use in patients suffering from neuroleptic malignant syndrome due to the increased risk of worsening of the patient's condition. Replacement with a suitable alternative should be considered based on the clinical condition of the patient.
Food interactions
Information not available.
Lab interactions
Information not available.
Take this medicine with or without food, as advised by your doctor. Do not take in larger or smaller amounts than advised/prescribed. Consult the doctor if you experience any undesirable side effects. Ensure that the treatment course is completed. Do not stop the use of this medicine without consulting your doctor.
Miscelleneous

Can be taken with or without food, as advised by your doctor

To be taken as instructed by doctor

May cause sleepiness

How it works
This medicine acts in place of dopamine, a natural substance present in the brain which is involved in various functions such as memory, attention, regulation of body movements, etc.
Legal Status

Approved

Approved

Approved

Approved

Classification

Category

Dopaminergic Antiparkinsonism agents

Schedule

Schedule H

[Internet]. Accessdata.fda.gov. 2018 [cited 25 July 2018]. Available from:

https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/020667s014s017s018lbl.pdf

[Internet]. Docs.boehringer-ingelheim.com. 2018 [cited 25 July 2018]. Available from:

https://docs.boehringer-ingelheim.com/Prescribing%20Information/PIs/Mirapex%20ER/MirapexER.pdf

Pramipexole - DrugBank [Internet]. Drugbank.ca. 2018 [cited 25 July 2018]. Available from:

https://www.drugbank.ca/drugs/DB00413

Pramipexole 0.18mg Tablets - Summary of Product Characteristics (SmPC) - (eMC) [Internet]. Medicines.org.uk. 2018 [cited 25 July 2018]. Available from:

https://www.medicines.org.uk/emc/product/3081/smpc

Pramipexole: MedlinePlus Drug Information [Internet]. Medlineplus.gov. 2018 [cited 25 July 2018]. Available from:

https://medlineplus.gov/druginfo/meds/a697029.html
Loading related questions...
Something doesn’t feel right?
Report an error

Information on this page was last updated on 27 Jul 2018

Disclaimer

We’ve made all possible efforts to ensure that the information provided here is accurate, up-to-date and complete, however, it should not be treated as a substitute for professional medical advice, diagnosis or treatment. Practo only provides reference source for common information on medicines and does not guarantee its accuracy or exhaustiveness. The absence of a warning for any drug or combination thereof, should not be assumed to indicate that the drug or combination is safe, effective, or appropriate for any given patient. Practo does not assume any responsibility for any aspect of healthcare administered with the aid of information provided above. If you have any doubts about your medication then we strongly recommend that you consult with your doctor, nurse or healthcare provider. See detailed T&C here.